https://medicaex.com/businesswire/imv-inc-to-announce-third-quarter-2022-results-and-host-a-conference-call-and-webcast-on-november-11-2022-2/ 2022-11-08T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/IMV_Logos_IMV-Logo_BrandStatement-axZmRu.jpeg https://medicaex.com/businesswire/global-dried-blood-spot-collection-cards-market-report-to-2030-use-of-dbs-cards-in-newborn-screening-is-driving-growth-researchandmarkets-com/ 2022-11-08T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6uyFhN.jpeg https://medicaex.com/businesswire/juvena-therapeutics-secures-41-million-to-accelerate-the-discovery-and-development-of-biologics-for-chronic-and-age-related-diseases-2/ 2022-11-08T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Juvena_Low-JUhZCt.jpeg https://medicaex.com/businesswire/bicycle-therapeutics-announces-first-patient-dosed-in-bt8009-phase-ii-expansion-cohorts-and-provides-program-update-2/ 2022-11-08T12:12:17+00:00 https://medicaex.com/businesswire/koru-medical-systems-announces-novel-therapy-collaboration-for-three-indications-with-kira-pharmaceuticals-3/ 2022-11-08T12:12:14+00:00 https://medicaex.com/businesswire/linear-health-sciences-receives-innovative-technology-contract-from-vizient-for-orchid-srv-iv-safety-device/ 2022-11-08T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/LHS_Corp_Logo_28129-Gmed2t.jpeg https://medicaex.com/businesswire/novanta-announces-financial-results-for-the-third-quarter-2022-2/ 2022-11-08T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/novanta_logo_rgb-iRx63t.jpeg https://medicaex.com/businesswire/infusystem-reports-third-quarter-2022-financial-results-2/ 2022-11-08T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-nxyuVR.jpeg https://medicaex.com/businesswire/koru-medical-systems-announces-novel-therapy-collaboration-for-three-indications-with-kira-pharmaceuticals-2/ 2022-11-08T12:12:12+00:00 https://medicaex.com/businesswire/bruker-announces-acquisition-of-inscopix-for-neuroscience-research/ 2022-11-08T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-QyE3H4.jpeg https://medicaex.com/businesswire/infusystem-reports-third-quarter-2022-financial-results/ 2022-11-08T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-14qqd0.jpeg https://medicaex.com/businesswire/koru-medical-systems-announces-novel-therapy-collaboration-for-three-indications-with-kira-pharmaceuticals/ 2022-11-08T12:12:10+00:00 https://medicaex.com/businesswire/adapthealth-corp-announces-third-quarter-2022-results-and-updates-2022-outlook/ 2022-11-08T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/adapthealth_greenblue_LOGO-LCbUfS.jpeg https://medicaex.com/businesswire/novanta-announces-financial-results-for-the-third-quarter-2022/ 2022-11-08T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/novanta_logo_rgb-1PM357.jpeg https://medicaex.com/businesswire/bicycle-therapeutics-announces-first-patient-dosed-in-bt8009-phase-ii-expansion-cohorts-and-provides-program-update/ 2022-11-08T12:12:07+00:00 https://medicaex.com/businesswire/precision-biosciences-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-08T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_BioSciences_logo-fAtiZn.jpeg https://medicaex.com/businesswire/biosimilar-interleukins-global-market-report-2022-rising-prevalence-of-autoimmune-conditions-spurring-growth-researchandmarkets-com/ 2022-11-08T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ycBZTv.jpeg https://medicaex.com/businesswire/imv-inc-to-announce-third-quarter-2022-results-and-host-a-conference-call-and-webcast-on-november-11-2022/ 2022-11-08T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/IMV_Logos_IMV-Logo_BrandStatement-u6mAO2.jpeg https://medicaex.com/businesswire/juvena-therapeutics-secures-41-million-to-accelerate-the-discovery-and-development-of-biologics-for-chronic-and-age-related-diseases/ 2022-11-08T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Juvena_Low-0qXrjV.jpeg https://medicaex.com/businesswire/mednow-opens-alberta-pharmacy-location/ 2022-11-08T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mednow_Primary_Horizontal_Logo_5BIcon_2B_Wordmark5D_RGB-iLgKiE.jpeg https://medicaex.com/businesswire/turnstone-biologics-to-present-preclinical-data-from-novel-til-therapy-demonstrating-tumor-reactive-t-cell-selection-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting-2/ 2022-11-08T11:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/TSTN_Logo_Twitter-TTCxga.jpeg https://medicaex.com/businesswire/aptorum-group-limited-to-hold-annual-general-meeting-of-shareholders-on-december-21-2022-2/ 2022-11-08T11:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/aptorum_hori_HQ-aW9KmN.jpeg https://medicaex.com/businesswire/perkinelmer-announces-financial-results-for-the-third-quarter-of-2022-3/ 2022-11-08T11:12:17+00:00 https://medicaex.com/businesswire/aver-europe-showcases-worlds-first-detachable-4k-8mp-handheld-camera-for-telemedicine-at-medica-expo-2022-2/ 2022-11-08T11:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVer_logo-iZszUP.jpeg https://medicaex.com/businesswire/dermavant-announces-highly-favorable-results-from-pediatric-maximal-usage-study-of-vtama-tapinarof-cream-1-in-atopic-dermatitis-2/ 2022-11-08T11:12:17+00:00 https://medicaex.com/businesswire/qnovia-to-pursue-uk-approval-for-lead-asset-qn-01-in-nicotine-replacement-therapy-2/ 2022-11-08T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Qnovia-PVTNbE.jpeg https://medicaex.com/businesswire/global-healthcare-cmo-market-report-2022-escalating-role-of-artificial-intelligence-technology-presents-opportunities-researchandmarkets-com/ 2022-11-08T11:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-q0gwjK.jpeg https://medicaex.com/businesswire/perkinelmer-announces-financial-results-for-the-third-quarter-of-2022-2/ 2022-11-08T11:12:11+00:00 https://medicaex.com/businesswire/qnovia-to-pursue-uk-approval-for-lead-asset-qn-01-in-nicotine-replacement-therapy/ 2022-11-08T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Qnovia-7qEewx.jpeg https://medicaex.com/businesswire/aver-europe-showcases-worlds-first-detachable-4k-8mp-handheld-camera-for-telemedicine-at-medica-expo-2022/ 2022-11-08T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVer_logo-6UYc88.jpeg https://medicaex.com/businesswire/global-cold-chain-pharma-market-outlook-report-2022-2027-compound-annual-growth-of-12-predicted-with-market-set-to-reach-12574-million-by-2027-researchandmarkets-com/ 2022-11-08T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Poxe5N.jpeg https://medicaex.com/businesswire/dermavant-announces-highly-favorable-results-from-pediatric-maximal-usage-study-of-vtama-tapinarof-cream-1-in-atopic-dermatitis/ 2022-11-08T11:12:07+00:00 https://medicaex.com/businesswire/turnstone-biologics-to-present-preclinical-data-from-novel-til-therapy-demonstrating-tumor-reactive-t-cell-selection-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting/ 2022-11-08T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/TSTN_Logo_Twitter-x8VFMh.jpeg https://medicaex.com/businesswire/aptorum-group-limited-to-hold-annual-general-meeting-of-shareholders-on-december-21-2022/ 2022-11-08T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/aptorum_hori_HQ-iMYuZk.jpeg https://medicaex.com/businesswire/perkinelmer-announces-financial-results-for-the-third-quarter-of-2022/ 2022-11-08T11:12:07+00:00 https://medicaex.com/businesswire/global-healthcare-medical-simulation-market-report-2022-limited-access-to-patients-during-medical-training-boosts-demand-researchandmarkets-com/ 2022-11-08T10:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KYDwBJ.jpeg https://medicaex.com/businesswire/vectory-appoints-sander-van-deventer-as-ceo-and-makes-key-appointments-to-its-leadership-team-3/ 2022-11-08T09:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/VectorY_logo-buqtxs.jpeg https://medicaex.com/businesswire/vectory-appoints-sander-van-deventer-as-ceo-and-makes-key-appointments-to-its-leadership-team-2/ 2022-11-08T09:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/VectorY_logo-SmTS1N.jpeg https://medicaex.com/businesswire/lifeworks-releases-the-results-of-its-performance-universe-of-pension-managers-pooled-funds-2/ 2022-11-08T09:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/TELUS_Health_LifeWorks_Hor_2022_Digital_RGB-EspWSl.jpeg https://medicaex.com/businesswire/vectory-appoints-sander-van-deventer-as-ceo-and-makes-key-appointments-to-its-leadership-team/ 2022-11-08T09:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/VectorY_logo-ILR7tY.jpeg https://medicaex.com/businesswire/lifeworks-releases-the-results-of-its-performance-universe-of-pension-managers-pooled-funds/ 2022-11-08T09:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/TELUS_Health_LifeWorks_Hor_2022_Digital_RGB-mFEz7l.jpeg https://medicaex.com/businesswire/virtual-dental-care-cigna-collaborate-to-expand-access-to-virtual-on-demand-dental-care-3/ 2022-11-08T08:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virtual_Dental_Care_and_Cigna-M6HXeb.jpeg https://medicaex.com/businesswire/virtual-dental-care-cigna-collaborate-to-expand-access-to-virtual-on-demand-dental-care-2/ 2022-11-08T08:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virtual_Dental_Care_and_Cigna-4cilVl.jpeg https://medicaex.com/businesswire/virtual-dental-care-cigna-collaborate-to-expand-access-to-virtual-on-demand-dental-care/ 2022-11-08T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virtual_Dental_Care_and_Cigna-ZOeYCL.jpeg https://medicaex.com/businesswire/onward-reports-third-quarter-2022-highlights-and-provides-business-update-2/ 2022-11-08T07:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-Lp0qnK.jpeg https://medicaex.com/businesswire/onward-reports-third-quarter-2022-highlights-and-provides-business-update/ 2022-11-08T07:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-pnXQld.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-pricing-of-60-million-public-offering/ 2022-11-08T05:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/marinus-color-0KyjBl.jpeg https://medicaex.com/businesswire/walgreens-boots-alliance-announces-offering-of-10-million-shares-of-amerisourcebergen-corporation/ 2022-11-08T04:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/WBA_logo_multi_pos-6jF7Ti.jpeg https://medicaex.com/businesswire/10-studies-on-orelabrutinib-selected-at-the-upcoming-64th-annual-meeting-of-ash-2/ 2022-11-08T01:12:13+00:00 https://medicaex.com/businesswire/snaplogic-powers-abano-healthcares-journey-to-modernisation/ 2022-11-08T01:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/SnapLogic_RGB-hZsetz.jpeg https://medicaex.com/businesswire/10-studies-on-orelabrutinib-selected-at-the-upcoming-64th-annual-meeting-of-ash/ 2022-11-08T01:12:07+00:00 https://medicaex.com/businesswire/align-technology-to-award-research-programs-that-advance-orthodontic-and-dental-patient-care-3/ 2022-11-08T00:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Align_tagline_vertical_RGB_charcoal_2c-qaXYYG.jpeg https://medicaex.com/businesswire/align-technology-to-award-research-programs-that-advance-orthodontic-and-dental-patient-care-2/ 2022-11-08T00:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Align_tagline_vertical_RGB_charcoal_2c-aMAXyT.jpeg https://medicaex.com/businesswire/align-technology-to-award-research-programs-that-advance-orthodontic-and-dental-patient-care/ 2022-11-08T00:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Align_tagline_vertical_RGB_charcoal_2c-RlrqJD.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order-2/ 2022-11-07T23:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO_28129-EpOcwF.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order/ 2022-11-07T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO_28129-iznQeQ.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-proposed-public-offering/ 2022-11-07T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/marinus-color-HW6zDX.jpeg https://medicaex.com/businesswire/arcturus-therapeutics-to-present-at-the-following-investor-conferences-in-november-2/ 2022-11-07T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/arcturus-logo-blueback-jhFWBe.jpeg https://medicaex.com/businesswire/teva-to-present-latest-research-from-the-connect1-and-connect2-clinical-trials-at-the-american-college-of-allergy-asthma-immunology-acaai-2022-annual-scientific-meeting-2/ 2022-11-07T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-xwVBkQ.jpeg https://medicaex.com/businesswire/geron-to-participate-in-stifel-2022-healthcare-conference-2/ 2022-11-07T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geron_Full_Logo_RGB-01-aMrVum.jpeg https://medicaex.com/businesswire/alpine-immune-sciences-to-report-third-quarter-2022-financial-results-2/ 2022-11-07T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/AIS-Logo-q7r7vq.jpeg https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-voting-results-from-2022-annual-and-special-meeting-of-shareholders-2/ 2022-11-07T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Perimeter_Logo_Horizontal_FullColor-K8PXPr.jpeg https://medicaex.com/businesswire/agilon-health-to-participate-in-wolfe-research-healthcare-conference/ 2022-11-07T22:12:09+00:00 https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-voting-results-from-2022-annual-and-special-meeting-of-shareholders/ 2022-11-07T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Perimeter_Logo_Horizontal_FullColor-gl54BP.jpeg https://medicaex.com/businesswire/kimball-electronics-reports-q1-results-with-record-sales-and-improving-year-over-year-operating-margin-company-affirms-guidance-for-fiscal-2023-with-full-year-expected-at-the-high-end-of-the-range-fo/ 2022-11-07T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/KImball_Electronics_Reports_Q1_Results2-lsTFIs.jpeg https://medicaex.com/businesswire/invacare-reports-results-for-third-quarter-2022/ 2022-11-07T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Invacare_Logo-bu6U9W.jpeg https://medicaex.com/businesswire/geron-to-participate-in-stifel-2022-healthcare-conference/ 2022-11-07T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geron_Full_Logo_RGB-01-mtBEdQ.jpeg https://medicaex.com/businesswire/alpine-immune-sciences-to-report-third-quarter-2022-financial-results/ 2022-11-07T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/AIS-Logo-rA2C37.jpeg https://medicaex.com/businesswire/amerisourcebergen-announces-secondary-public-offering-of-common-shares-and-common-share-repurchase/ 2022-11-07T22:12:04+00:00 https://medicaex.com/businesswire/arcturus-therapeutics-to-present-at-the-following-investor-conferences-in-november/ 2022-11-07T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/arcturus-logo-blueback-mCGg6o.jpeg https://medicaex.com/businesswire/teva-to-present-latest-research-from-the-connect1-and-connect2-clinical-trials-at-the-american-college-of-allergy-asthma-immunology-acaai-2022-annual-scientific-meeting/ 2022-11-07T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-yaReaj.jpeg https://medicaex.com/businesswire/docgo-announces-strong-third-quarter-2022-results/ 2022-11-07T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-9AAqIM.jpeg https://medicaex.com/businesswire/arrowhead-presents-new-phase-2-data-at-aha-2022-on-cardiometabolic-pipeline-2/ 2022-11-07T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-e7fLzR.jpeg https://medicaex.com/businesswire/fulgent-genetics-acquires-fulgent-pharma-creating-a-new-paradigm-in-precision-medicine-for-the-company-2/ 2022-11-07T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/FLGT_Logo-k7R0i3.jpeg https://medicaex.com/businesswire/qiagen-exceeds-outlook-for-q3-2022-with-18-cer-sales-growth-in-non-covid-product-portfolio-and-raises-full-year-2022-outlook-2/ 2022-11-07T21:12:12+00:00 https://medicaex.com/businesswire/quantum-si-reports-third-quarter-2022-financial-results-2/ 2022-11-07T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/QuantumSi_Logo_Horizontal_RGB-tC7QXV.jpeg https://medicaex.com/businesswire/conmed-corporation-to-participate-in-a-fireside-chat-at-the-stifel-2022-healthcare-conference-3/ 2022-11-07T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-u9WzQI.jpeg https://medicaex.com/businesswire/quantum-si-reports-third-quarter-2022-financial-results/ 2022-11-07T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/QuantumSi_Logo_Horizontal_RGB-e2hzHb.jpeg https://medicaex.com/businesswire/conmed-corporation-to-participate-in-a-fireside-chat-at-the-stifel-2022-healthcare-conference-2/ 2022-11-07T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-PUYQik.jpeg https://medicaex.com/businesswire/personalis-presents-data-from-new-platform-features-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting-2/ 2022-11-07T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-lnTS8k.jpeg https://medicaex.com/businesswire/qiagen-exceeds-outlook-for-q3-2022-with-18-cer-sales-growth-in-non-covid-product-portfolio-and-raises-full-year-2022-outlook/ 2022-11-07T21:12:09+00:00 https://medicaex.com/businesswire/amwell-announces-results-for-third-quarter-2022-2/ 2022-11-07T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/amwell_logo-QTEJGl.jpeg https://medicaex.com/businesswire/conmed-corporation-to-participate-in-a-fireside-chat-at-the-stifel-2022-healthcare-conference/ 2022-11-07T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-4Jvymx.jpeg https://medicaex.com/businesswire/vicarious-surgical-reports-third-quarter-2022-financial-results/ 2022-11-07T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-AboKH3.jpeg https://medicaex.com/businesswire/establishment-labs-reports-third-quarter-2022-financial-results/ 2022-11-07T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/el-logo-2018-OLQSdV.jpeg https://medicaex.com/businesswire/navidea-biopharmaceuticals-announces-details-of-presentation-at-upcoming-society-for-immunotherapy-of-cancer-annual-meeting/ 2022-11-07T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/navidea_cmyk-mxsql7.jpeg https://medicaex.com/businesswire/personalis-presents-data-from-new-platform-features-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting/ 2022-11-07T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-VrvWny.jpeg https://medicaex.com/businesswire/2seventy-bio-reports-third-quarter-financial-results-and-recent-operational-progress/ 2022-11-07T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/2seventy_logo_for_BW-1PylEK.jpeg https://medicaex.com/businesswire/fulgent-genetics-acquires-fulgent-pharma-creating-a-new-paradigm-in-precision-medicine-for-the-company/ 2022-11-07T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/FLGT_Logo-6zzJDf.jpeg https://medicaex.com/businesswire/arrowhead-presents-new-phase-2-data-at-aha-2022-on-cardiometabolic-pipeline/ 2022-11-07T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-7ke3om.jpeg https://medicaex.com/businesswire/amwell-announces-results-for-third-quarter-2022/ 2022-11-07T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/amwell_logo-pZwPH8.jpeg https://medicaex.com/businesswire/poxel-presents-destiny-1-phase-2-results-for-pxl065-in-nash-at-aasld-the-liver-meeting-2022-2/ 2022-11-07T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Without_Background-6FjcQc.jpeg https://medicaex.com/businesswire/anumana-acquires-neutrace-establishing-a-comprehensive-electrophysiology-deep-learning-development-platform-and-product-pipeline-2/ 2022-11-07T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-XonpiK.jpeg https://medicaex.com/businesswire/anumana-acquires-neutrace-establishing-a-comprehensive-electrophysiology-deep-learning-development-platform-and-product-pipeline/ 2022-11-07T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-wySefR.jpeg https://medicaex.com/businesswire/poxel-presents-destiny-1-phase-2-results-for-pxl065-in-nash-at-aasld-the-liver-meeting-2022/ 2022-11-07T20:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Without_Background-qU4g5x.jpeg https://medicaex.com/businesswire/global-patient-derived-xenograft-pdx-model-market-research-report-to-2027-featuring-champions-oncology-envigo-genesis-biotechnology-and-sr-among-others-researchandmarkets-com-2/ 2022-11-07T19:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-8W3kgF.jpeg https://medicaex.com/businesswire/the-worldwide-recombinant-proteins-industry-is-expected-to-reach-8-6-billion-by-2027-researchandmarkets-com-2/ 2022-11-07T19:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-zWBHNe.jpeg https://medicaex.com/businesswire/medincell-announces-the-initiation-of-phase-3-study-of-f14-mdc-cwm-a-therapeutic-first-in-class-that-aims-to-provide-weeks-of-localized-pain-relief-after-total-knee-replacement/ 2022-11-07T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/4773316cLogo_MedinCell_registered-CT74bc.jpeg https://medicaex.com/businesswire/global-contrast-media-injectors-market-report-2022-regulatory-approval-of-an-increasing-number-of-contrast-agents-driving-growth-researchandmarkets-com-2/ 2022-11-07T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Zcoj2a.jpeg https://medicaex.com/businesswire/global-contrast-media-injectors-market-report-2022-regulatory-approval-of-an-increasing-number-of-contrast-agents-driving-growth-researchandmarkets-com/ 2022-11-07T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-No2c8k.jpeg https://medicaex.com/businesswire/global-patient-derived-xenograft-pdx-model-market-research-report-to-2027-featuring-champions-oncology-envigo-genesis-biotechnology-and-sr-among-others-researchandmarkets-com/ 2022-11-07T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-f66HSc.jpeg https://medicaex.com/businesswire/the-worldwide-recombinant-proteins-industry-is-expected-to-reach-8-6-billion-by-2027-researchandmarkets-com/ 2022-11-07T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pRrkOy.jpeg https://medicaex.com/businesswire/global-celiac-disease-market-research-report-2022-players-include-abbott-laboratories-abbvie-bayer-and-calypso-biotech-researchandmarkets-com-3/ 2022-11-07T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6NHtWZ.jpeg https://medicaex.com/businesswire/global-microarray-market-report-2022-rise-in-the-usage-of-microarrays-in-various-applications-drives-growth-researchandmarkets-com/ 2022-11-07T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-x2eisf.jpeg https://medicaex.com/businesswire/mirum-presents-new-data-from-livmarli-phase-3-pfic-study-and-algs-infant-study-in-late-breaker-presentations-at-the-liver-meeting-of-aasld-2/ 2022-11-07T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mirum_Inline_FullColor_RGB-U3KyoT.jpeg https://medicaex.com/businesswire/aleta-biotherapeutics-receives-innovation-passport-designation-for-biologic-car-t-cell-therapy-engager-aleta-001-2/ 2022-11-07T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aleta_Logo-alI95X.jpeg https://medicaex.com/businesswire/dispensing-pharmacy-packaging-machine-global-market-report-2022-rising-biopharma-industry-fueling-growth-researchandmarkets-com-2/ 2022-11-07T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mPahQy.jpeg https://medicaex.com/businesswire/north-america-micro-surgical-robot-market-report-2022-technological-advancements-in-further-miniaturization-of-micro-surgical-robots-presents-opportunities-researchandmarkets-com-2/ 2022-11-07T18:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-igUNwU.jpeg https://medicaex.com/businesswire/north-america-micro-surgical-robot-market-report-2022-technological-advancements-in-further-miniaturization-of-micro-surgical-robots-presents-opportunities-researchandmarkets-com/ 2022-11-07T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-HhMqsT.jpeg https://medicaex.com/businesswire/global-peptide-therapeutics-market-report-2022-adoption-of-new-platforms-that-develop-next-generation-protein-or-peptide-therapeutics-drives-growth-researchandmarkets-com/ 2022-11-07T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-35Nm76.jpeg https://medicaex.com/businesswire/aleta-biotherapeutics-receives-innovation-passport-designation-for-biologic-car-t-cell-therapy-engager-aleta-001/ 2022-11-07T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aleta_Logo-bv9drw.jpeg https://medicaex.com/businesswire/dispensing-pharmacy-packaging-machine-global-market-report-2022-rising-biopharma-industry-fueling-growth-researchandmarkets-com/ 2022-11-07T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-tlOqML.jpeg https://medicaex.com/businesswire/global-celiac-disease-market-research-report-2022-players-include-abbott-laboratories-abbvie-bayer-and-calypso-biotech-researchandmarkets-com/ 2022-11-07T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-faPgSn.jpeg https://medicaex.com/businesswire/mirum-presents-new-data-from-livmarli-phase-3-pfic-study-and-algs-infant-study-in-late-breaker-presentations-at-the-liver-meeting-of-aasld/ 2022-11-07T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mirum_Inline_FullColor_RGB-E86iFC.jpeg https://medicaex.com/businesswire/maat-pharma-announces-participation-in-scientific-and-investor-conferences-in-november-2/ 2022-11-07T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-vPq9NA.jpeg https://medicaex.com/businesswire/new-digital-tool-dramatically-reduces-blood-clot-risk-during-and-post-hospital-care-feinstein-institutes-study-shows-2/ 2022-11-07T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Spy_2-k06t3L.jpeg https://medicaex.com/businesswire/medidata-gathers-life-sciences-leaders-to-solve-their-impossible-at-next-new-york-conference/ 2022-11-07T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/3DS_MEDIDATA_Logotype_RGB_PRIMARY_28129-VydcEd.jpeg https://medicaex.com/businesswire/nomi-health-announces-november-launch-of-keiki-book-drive-4/ 2022-11-07T17:12:12+00:00 https://medicaex.com/businesswire/andreessen-horowitz-bio-health-fund-and-bassett-healthcare-network-leverage-digital-health-to-address-rural-healthcare-needs/ 2022-11-07T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/a16z-BioHealth-Logo-dp8Awf.jpeg https://medicaex.com/businesswire/global-vitreo-retinal-surgery-devices-pipeline-report-2022-update-formulate-significant-competitor-information-analysis-and-insights-to-improve-rd-strategies-researchandmarkets-com-2/ 2022-11-07T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Zrk3e5.jpeg https://medicaex.com/businesswire/global-vitreo-retinal-surgery-devices-pipeline-report-2022-update-formulate-significant-competitor-information-analysis-and-insights-to-improve-rd-strategies-researchandmarkets-com/ 2022-11-07T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-DHGqnm.jpeg https://medicaex.com/businesswire/global-power-assist-wheelchair-market-report-2022-to-2027-featuring-alber-permobil-todo-works-and-batec-mobility-among-others-researchandmarkets-com/ 2022-11-07T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-wWfLKj.jpeg https://medicaex.com/businesswire/soleo-health-awarded-national-accreditations-in-three-programs-from-the-joint-commission-2/ 2022-11-07T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021-W7p6Ed.jpeg https://medicaex.com/businesswire/nomi-health-announces-november-launch-of-keiki-book-drive-2/ 2022-11-07T17:12:08+00:00 https://medicaex.com/businesswire/soleo-health-awarded-national-accreditations-in-three-programs-from-the-joint-commission/ 2022-11-07T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021-WhPut7.jpeg https://medicaex.com/businesswire/new-digital-tool-dramatically-reduces-blood-clot-risk-during-and-post-hospital-care-feinstein-institutes-study-shows/ 2022-11-07T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Spy_2-gjGvy3.jpeg https://medicaex.com/businesswire/poxel-announces-upcoming-participation-at-the-jefferies-london-healthcare-conference/ 2022-11-07T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Without_Background-GmnDVT.jpeg https://medicaex.com/businesswire/global-retinitis-pigmentosa-clinical-trial-pipeline-highlights-report-2022-look-at-active-clinical-development-stages-including-early-and-late-stage-clinical-trials-researchandmarkets-com/ 2022-11-07T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QBZd8r.jpeg https://medicaex.com/businesswire/nomi-health-announces-november-launch-of-keiki-book-drive/ 2022-11-07T17:12:04+00:00 https://medicaex.com/businesswire/maat-pharma-announces-participation-in-scientific-and-investor-conferences-in-november/ 2022-11-07T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-jyFMXw.jpeg https://medicaex.com/businesswire/global-hollow-fiber-filtration-market-report-2022-players-include-asahi-kasei-cantel-medical-coorstek-and-danaher-researchandmarkets-com-2/ 2022-11-07T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mjz4Nk.jpeg https://medicaex.com/businesswire/outside-the-us-bayer-extends-development-program-for-investigational-product-elinzanetant-with-phase-iii-study-in-breast-cancer-patients-with-vasomotor-symptoms-caused-by-endocrine-therapy-2/ 2022-11-07T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-0uNWhv.jpeg https://medicaex.com/businesswire/global-hearing-aids-3d-printing-devices-market-to-grow-by-384-7-million-during-2022-2026-researchandmarkets-com-3/ 2022-11-07T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MVli7K.jpeg https://medicaex.com/businesswire/tivic-health-takes-bioelectronic-medicine-to-htlh-3/ 2022-11-07T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-PJ4vem.jpeg https://medicaex.com/businesswire/outlook-on-the-cell-gene-therapy-clinical-trials-global-market-to-2027-by-phase-application-and-region-researchandmarkets-com-2/ 2022-11-07T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-A3O51p.jpeg https://medicaex.com/businesswire/tivic-health-takes-bioelectronic-medicine-to-htlh-2/ 2022-11-07T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-B5dQcc.jpeg https://medicaex.com/businesswire/global-hearing-aids-3d-printing-devices-market-to-grow-by-384-7-million-during-2022-2026-researchandmarkets-com-2/ 2022-11-07T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-zqAEV7.jpeg https://medicaex.com/businesswire/the-worldwide-pupillometer-industry-is-expected-to-reach-667-5-million-by-2027-researchandmarkets-com/ 2022-11-07T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-o68qMx.jpeg https://medicaex.com/businesswire/global-hearing-aids-3d-printing-devices-market-to-grow-by-384-7-million-during-2022-2026-researchandmarkets-com/ 2022-11-07T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-c7amtc.jpeg https://medicaex.com/businesswire/insights-on-the-ophthalmic-handheld-surgical-instruments-global-market-to-2027-development-of-smart-surgical-tools-and-augmenting-devices-presents-opportunities-researchandmarkets-com/ 2022-11-07T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-srmvhp.jpeg https://medicaex.com/businesswire/tivic-health-takes-bioelectronic-medicine-to-htlh/ 2022-11-07T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-3HSuTv.jpeg https://medicaex.com/businesswire/6-4-billion-worldwide-in-vivo-cro-industry-to-2027-increasing-usage-of-outsourcing-services-due-to-economic-benefits-is-driving-growth-researchandmarkets-com/ 2022-11-07T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ipdNiC.jpeg https://medicaex.com/businesswire/outlook-on-the-cell-gene-therapy-clinical-trials-global-market-to-2027-by-phase-application-and-region-researchandmarkets-com/ 2022-11-07T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-nevHwX.jpeg https://medicaex.com/businesswire/global-hollow-fiber-filtration-market-report-2022-players-include-asahi-kasei-cantel-medical-coorstek-and-danaher-researchandmarkets-com/ 2022-11-07T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-zBkeVZ.jpeg https://medicaex.com/businesswire/outside-the-us-bayer-extends-development-program-for-investigational-product-elinzanetant-with-phase-iii-study-in-breast-cancer-patients-with-vasomotor-symptoms-caused-by-endocrine-therapy/ 2022-11-07T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-5p6TMX.jpeg https://medicaex.com/businesswire/phil-patient-access-platform-capabilities-support-move-to-digital-prescription-models-3/ 2022-11-07T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-lMCqn4.jpeg https://medicaex.com/businesswire/nucleai-launches-new-multiplex-imaging-spatial-analysis-solution-to-increase-reliability-and-speed-of-immunofluorescence-analysis-for-drug-discovery-and-development-3/ 2022-11-07T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-3SEfUB.jpeg https://medicaex.com/businesswire/biote-appoints-debby-morris-to-board-of-directors/ 2022-11-07T15:12:12+00:00 https://medicaex.com/businesswire/phil-patient-access-platform-capabilities-support-move-to-digital-prescription-models-2/ 2022-11-07T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-RqlbvP.jpeg https://medicaex.com/businesswire/videra-health-uses-ai-assisted-video-assessments-to-help-signature-healthcare-services-improve-long-term-outcomes-for-behavioral-health-patients-2/ 2022-11-07T15:12:10+00:00 https://medicaex.com/businesswire/nucleai-launches-new-multiplex-imaging-spatial-analysis-solution-to-increase-reliability-and-speed-of-immunofluorescence-analysis-for-drug-discovery-and-development-2/ 2022-11-07T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-RYcYDw.jpeg https://medicaex.com/businesswire/telehealth-and-telemedicine-global-market-report-2022-manufacturers-focus-on-low-penetration-high-growth-markets-crucial-for-sector-researchandmarkets-com-2/ 2022-11-07T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Vkd4ec.jpeg https://medicaex.com/businesswire/global-influenza-diagnostics-market-report-to-2029-featuring-f-hoffmann-la-roche-quidel-thermo-fisher-scientific-abbott-laboratories-and-hologic-among-others-researchandmarkets-com/ 2022-11-07T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RP60pv.jpeg https://medicaex.com/businesswire/global-insulin-syringes-market-2022-2026-rising-rates-of-diabetes-worldwide-driving-4-69-growth-researchandmarkets-com-2/ 2022-11-07T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-SRHJi0.jpeg https://medicaex.com/businesswire/nucleai-launches-new-multiplex-imaging-spatial-analysis-solution-to-increase-reliability-and-speed-of-immunofluorescence-analysis-for-drug-discovery-and-development/ 2022-11-07T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-oqyJL1.jpeg https://medicaex.com/businesswire/villagemd-acquires-summit-health-citymd-creating-one-of-the-largest-independent-provider-groups-in-the-u-s/ 2022-11-07T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/WBA_logo_multi_pos-gfOpxG.jpeg https://medicaex.com/businesswire/phil-patient-access-platform-capabilities-support-move-to-digital-prescription-models/ 2022-11-07T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-bOazSi.jpeg https://medicaex.com/businesswire/global-insulin-syringes-market-2022-2026-rising-rates-of-diabetes-worldwide-driving-4-69-growth-researchandmarkets-com/ 2022-11-07T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RPBoBj.jpeg https://medicaex.com/businesswire/videra-health-uses-ai-assisted-video-assessments-to-help-signature-healthcare-services-improve-long-term-outcomes-for-behavioral-health-patients/ 2022-11-07T15:12:03+00:00 https://medicaex.com/businesswire/telehealth-and-telemedicine-global-market-report-2022-manufacturers-focus-on-low-penetration-high-growth-markets-crucial-for-sector-researchandmarkets-com/ 2022-11-07T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-e4oKWW.jpeg https://medicaex.com/businesswire/meissa-vaccines-announces-positive-interim-clinical-data-for-its-intranasal-live-attenuated-respiratory-syncytial-virus-rsv-vaccine-candidate-for-infants-2/ 2022-11-07T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Meissa_Logo-YdKpWs.jpeg https://medicaex.com/businesswire/maxwell-biosciences-names-two-biotech-leaders-to-its-board-of-directors-2/ 2022-11-07T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Maxwell_Logo_2800229-46LIIR.jpeg https://medicaex.com/businesswire/therapeutic-solutions-international-spin-off-res-nova-bio-collaborates-with-veltmeyer-md-inc-to-provide-breast-cancer-patients-access-to-novel-cancer-immunotherapy/ 2022-11-07T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_tsoi-UJHkAl.jpeg https://medicaex.com/businesswire/60-7-million-worldwide-bioprocess-validation-industry-to-2027-featuring-merck-pall-sartorius-stedim-biotech-sgs-and-eurofins-scientific-among-others-researchandmarkets-com/ 2022-11-07T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-nyMsTF.jpeg https://medicaex.com/businesswire/merck-synergis-ips-present-on-engineering-document-management-for-simplified-compliance-validation-2/ 2022-11-07T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_11_LifeSciences_social-11-3-2022-SSS7oH.jpeg https://medicaex.com/businesswire/baxter-highlights-new-home-dialysis-and-hdx-therapy-data-in-14-clinical-presentations-at-kidney-week-2022-2/ 2022-11-07T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bxtlogo_300dpi-lVgeqO.jpeg https://medicaex.com/businesswire/the-next-generation-contact-center-for-healthcare-has-arrived/ 2022-11-07T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Innovaccer_Logo-oRat3D.jpeg https://medicaex.com/businesswire/tivic-health-to-report-third-quarter-2022-financial-results-on-monday-november-14th/ 2022-11-07T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-8sAb62.jpeg https://medicaex.com/businesswire/know-labs-participating-in-second-annual-bernstein-cgm-disruptors-conference-2/ 2022-11-07T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Know_Labs_Logo-xPzJgH.jpeg https://medicaex.com/businesswire/whoop-and-tyr-partner-to-optimize-swimming-performance/ 2022-11-07T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/TYR_Whoop_Michael_Andrew_5-BCKYWQ.jpeg https://medicaex.com/businesswire/know-labs-participating-in-second-annual-bernstein-cgm-disruptors-conference/ 2022-11-07T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Know_Labs_Logo-xsAK6c.jpeg https://medicaex.com/businesswire/global-monoclonal-antibody-therapeutics-market-2022-to-2027-increasing-investment-in-rd-and-increase-in-product-launches-present-opportunities-researchandmarkets-com/ 2022-11-07T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TzFE2P.jpeg https://medicaex.com/businesswire/baxter-highlights-new-home-dialysis-and-hdx-therapy-data-in-14-clinical-presentations-at-kidney-week-2022/ 2022-11-07T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bxtlogo_300dpi-QDhw9s.jpeg https://medicaex.com/businesswire/global-minimally-invasive-surgery-mis-market-report-2022-increasing-adoption-of-advanced-robotics-in-ascs-presents-opportunities-researchandmarkets-com/ 2022-11-07T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-03d2Ya.jpeg https://medicaex.com/businesswire/the-worldwide-blood-temperature-indicator-industry-is-expected-to-reach-504-3-million-by-2028-at-a-12-9-cagr-researchandmarkets-com/ 2022-11-07T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-dmkBP0.jpeg https://medicaex.com/businesswire/meissa-vaccines-announces-positive-interim-clinical-data-for-its-intranasal-live-attenuated-respiratory-syncytial-virus-rsv-vaccine-candidate-for-infants/ 2022-11-07T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Meissa_Logo-b39NAw.jpeg https://medicaex.com/businesswire/maxwell-biosciences-names-two-biotech-leaders-to-its-board-of-directors/ 2022-11-07T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Maxwell_Logo_2800229-ixNc0H.jpeg https://medicaex.com/businesswire/merck-synergis-ips-present-on-engineering-document-management-for-simplified-compliance-validation/ 2022-11-07T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_11_LifeSciences_social-11-3-2022-FfteMV.jpeg https://medicaex.com/businesswire/global-small-molecule-drug-discovery-market-report-2022-increase-in-rd-spending-boosts-sector-growth-researchandmarkets-com/ 2022-11-07T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-DLD2QP.jpeg https://medicaex.com/businesswire/the-worldwide-ultrafiltration-industry-is-expected-to-reach-5-72-billion-by-2030-researchandmarkets-com/ 2022-11-07T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-SFOji2.jpeg https://medicaex.com/businesswire/empire-bluecross-blueshield-and-crains-new-york-business-award-25-whole-health-heroes/ 2022-11-07T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/EBS_WHP_CMYK-dOkOgt.jpeg https://medicaex.com/businesswire/affini-t-therapeutics-to-present-preclinical-data-from-its-lead-programs-targeting-kras-g12v-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting-2/ 2022-11-07T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Affini-T_Therapeutics_logo-ra85mT.jpeg https://medicaex.com/businesswire/calidi-biotherapeutics-presents-promising-pre-clinical-data-from-supernova-1-snv1-a-novel-oncolytic-cell-based-platform-at-the-society-for-immunotherapy-of-cancers-37th-annual-meeting-si-2/ 2022-11-07T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/CalidiBiotherapeutics-Logo402x-enuKeT.jpeg https://medicaex.com/businesswire/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch-3/ 2022-11-07T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/AviClear_National_Press_Release_Image-NreOaI.jpeg https://medicaex.com/businesswire/a2-bio-identifying-solid-tumor-patients-for-possible-inclusion-in-phase-1-studies-targeting-cea-and-mesothelin-expected-to-begin-in-2023-update-at-sitc-2022-2/ 2022-11-07T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/A2-BIO-LOGO-Wd9Rv3.jpeg https://medicaex.com/businesswire/onestudyteam-and-antidote-partner-to-maximize-clinical-trial-recruitment-and-enrollment-3/ 2022-11-07T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/ost-inline-lockup-spruce-bOa2la.jpeg https://medicaex.com/businesswire/vicarious-surgical-announces-memorandum-of-understanding-agreement-with-pittsburgh-creates-to-advance-system-design-2/ 2022-11-07T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-P8g57G.jpeg https://medicaex.com/businesswire/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch-2/ 2022-11-07T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AviClear_National_Press_Release_Image-NRJM2n.jpeg https://medicaex.com/businesswire/oxular-limited-appoints-industry-veteran-james-jogerst-as-chief-business-officer-2/ 2022-11-07T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-YKBQ8o.jpeg https://medicaex.com/businesswire/freestyle-partners-receives-two-european-patents-for-use-of-filtered-far-uv-c-light-in-handheld-devices/ 2022-11-07T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/FreestylePartnersHorizLogo600-qn68jh.jpeg https://medicaex.com/businesswire/onestudyteam-and-antidote-partner-to-maximize-clinical-trial-recruitment-and-enrollment-2/ 2022-11-07T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/ost-inline-lockup-spruce-zMOGRQ.jpeg https://medicaex.com/businesswire/charles-river-announces-cell-therapy-manufacturing-capacity-expansion-reinforcing-commitment-to-cdmo-clients/ 2022-11-07T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-Uby3Jw.jpeg https://medicaex.com/businesswire/bigfoot-biomedical-announces-insulin-compatibility-expansion-to-support-insulin-affordability-and-flexibility-for-people-with-diabetes/ 2022-11-07T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/BFB_LogoPrim_TM-jc8UDO.jpeg https://medicaex.com/businesswire/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch/ 2022-11-07T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/AviClear_National_Press_Release_Image-w00pqG.jpeg https://medicaex.com/businesswire/oxular-limited-appoints-industry-veteran-james-jogerst-as-chief-business-officer/ 2022-11-07T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Pcjfki.jpeg https://medicaex.com/businesswire/vicarious-surgical-announces-memorandum-of-understanding-agreement-with-pittsburgh-creates-to-advance-system-design/ 2022-11-07T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-YhFfCl.jpeg https://medicaex.com/businesswire/onestudyteam-and-antidote-partner-to-maximize-clinical-trial-recruitment-and-enrollment/ 2022-11-07T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ost-inline-lockup-spruce-I3DXaY.jpeg https://medicaex.com/businesswire/affini-t-therapeutics-to-present-preclinical-data-from-its-lead-programs-targeting-kras-g12v-at-the-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting/ 2022-11-07T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Affini-T_Therapeutics_logo-My8Ie8.jpeg https://medicaex.com/businesswire/calidi-biotherapeutics-presents-promising-pre-clinical-data-from-supernova-1-snv1-a-novel-oncolytic-cell-based-platform-at-the-society-for-immunotherapy-of-cancers-37th-annual-meeting-si/ 2022-11-07T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CalidiBiotherapeutics-Logo402x-QWrWQK.jpeg https://medicaex.com/businesswire/avilar-therapeutics-presents-new-in-vivo-non-human-primate-data-for-asgpr-targeting-chimeras-atacs-at-the-keystone-symposium-on-targeted-protein-degradation/ 2022-11-07T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Avilar_logo-L1mY0m.jpeg